论文部分内容阅读
本报告主要提供上次会议(1975)以来所取得的进展。主要包括:一种简化命名法;复习在特异性诊断方面所取得的重要进展以及由此得以识别出一种与甲、乙两型肝炎病毒无关的新型肝炎,这种新型肝炎目前在某些地区是输血后肝炎中最常见的一类。另一进展是:使用感染甲型和乙型肝炎病毒的实验动物模型,很有可能在实验室中研究这两种病原体的感染性以及在进行人体试验前就有可能评价实验性乙型肝炎疫苗的安全性和有效性。有关抗乙型肝炎的新的被动免疫研究和对于治疗本病所做的大有希望的尝试也包括在本报告中。
This report mainly provides the progress made since the last meeting (1975). Mainly include: a simplified nomenclature; Review of the important advances made in the diagnosis of specificity and thus to identify a new type of hepatitis A and B hepatitis has nothing to do with the new hepatitis, the new hepatitis currently in some areas Is the most common type of hepatitis after transfusion. Another development is that using experimental animal models infected with both Hepatitis A and B viruses, it is possible to investigate the infectivity of both pathogens in the laboratory and to evaluate experimental Hepatitis B vaccines before conducting human trials The safety and effectiveness. New passive immunization studies on hepatitis B and promising attempts to treat this disease are also included in this report.